Nov 11, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Nov 12, 2019 -
It’s been a rough 2019 for some biotechs. Amneal Pharmaceuticals Inc (NYSE: AMRX) is down 81% year-to-date, while Teva Pharmaceutical Industries Ltd (NYSE: TEVA) is down 41%.
Nov 19, 2019 - Teva, Bausch Could Be Next to File for Bankruptcy, Stocks: AKAOQ,PTXTQ,TEVA,BHC,ENDP,AMRX,AKRX,AMAG,CLVS, release date:Nov 19, 2019
Nov 20, 2019 - Thanks to its debt offering, a heavily dilutive equity issuance has become very unlikely.The upsized offering also highlights that debt markets are not seeing a large bankruptcy risk.The only remainin
Nov 21, 2019 - The FDA accepts Endo's (ENDP) BLA for CCH for the treatment of cellulite in the buttocks.
Nov 25, 2019 - Teva Pharmaceuticals (TEVA +6.5%) pops higher in morning trade following a Bloomberg report that it has held talks with the U.S. Department of Justice about resolving a criminal antitrust probe of all
Nov 26, 2019 - Shares of generic drugmakers rose on Monday on a possible end to the persistent price-fixing probe.
Nov 20, 2019 -